PPT-Switching From a Tenofovir

Author : yael | Published Date : 2024-10-25

Disoproxil Fumarate TDFBased Regimen to a Tenofovir Alafenamide TAFBased Regimen Data in Virologically Suppressed Adults Through 48 Weeks of Treatment Anthony

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Switching From a Tenofovir" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Switching From a Tenofovir: Transcript


Disoproxil Fumarate TDFBased Regimen to a Tenofovir Alafenamide TAFBased Regimen Data in Virologically Suppressed Adults Through 48 Weeks of Treatment Anthony Mills 1 . These principles apply to bank account switching when consumers switch their payments relationships from their previous banks to their new banks in Finland Payments relationships here refer to recurring payments such as incoming and outgoing credit Patra. . Capelli. & Nan . Mya. . Oo. Outline. Research Question. Definition of Code-switching . Literature Review. Methodology. Data Analysis and Discussion. Conclusion & Recommendations. based . PrEP. technologies in women : . what do we currently know?. Linda-Gail Bekker . The Desmond Tutu HIV Centre. University of Cape Town.. Expanding HIV Prevention Options for Women.. The need for a female initiated, managed and controlled prevention methodology.. Ultrafast Conference on Magnetism. J. Barker. 1. , . T. Ostler. 1. , O. Hovorka. 1. , U. Atxitia. 1,2. , O. Chubykalo-Fesenko. 2. and . R. W. . Chantrell. 1. 1. Dept. of Physics, The University of York, York, United Kingdom.. Hakim . Weatherspoon. Assistant Professor, . Dept. of Computer Science. CS 5413: High Performance Systems and Networking. February 27, 2017. Slides used and adapted judiciously . from Computer Networking, A Top-Down Approach. New Treatments for HIV. C. Ryan Tomlin, . Pharm.D. ., BCPS, AAHIVP. Mercy Health Saint Mary’s. Grand Rapids, Michigan. Outline. Newly Released Antiretroviral Medications. Isentress. HD. ® (. raltegravir. Program. Improving Health. . . Promoting Wellness. QUARTERLY . SUMMARY. 3rd Quarter. October-December 2017. 2017/2018 Ryan White Grant Year. COUNTY HEALTH DEPARTMENTS . BY PHARMACY CATEGORY. PUTNAM. MARION. Treatment-naïve Patients . Clinical Instructor, Harvard Medical School. Director of Research, CRI New England. Vice Chair, INSIGHT Scientific Steering Committee. Boston, USA . Calvin Cohen, MD, MSc. A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borkar. 1. ,M.Kulkarni. 1. ,M.Dravid. 3. 1. . Ruby hall clinic, Department of HIV Medicine, . Pune. , India. 2. Ruby hall clinic, Department of Nephrology, . Program. Improving Health. . . Promoting Wellness. QUARTERLY . SUMMARY. 2nd Quarter. July-September 2017. 2017/2018 Ryan White Grant Year. COUNTY HEALTH DEPARTMENTS . BY PHARMACY CATEGORY. PUTNAM. MARION. TOTEM. Switching the NRTI Backbone to Tenofovir DF-Emtricitabine. TOTEM: Study Design. Source. : . Valantin. MA, et al. . J . Antimicrob. . Chemother. . 2010;65:556-61.. TDF-FTC + Continue . 3. rd. STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine. STEAL: Study Design. Source: . Martin A, et al. . Clin. Infect . Dis. 2009;49:1591. -1601. .. Study Design: STEAL. Background. FTC. Study 311-1089. Switching from TDF/FTC to TAF/. FTC. Study 311: Design. Source. : Gallant JE, et al. Lancet HIV. 2016;3:e158-65.. Switch to TAF/FTC*. . (n = 333). Continue TDF/FTC. (n = 330). *Patients on a pharmacokinetic booster (ritonavir) received tenofovir alafenamide-emtricitabine 10/200 mg. Tenofovir. . Disoproxil. . Fumarate. to . Tenofovir. . Alafenamide. Have Improved Renal and Bone Safety through 48 Weeks. Study GS-US-292-0112. Samir K. Gupta. 1. , Anton Pozniak. 2. , Jose Arribas.

Download Document

Here is the link to download the presentation.
"Switching From a Tenofovir"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents